Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_153ef54c27d646ae3ee15f7e8c809a3f |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-503 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-22 |
filingDate |
2010-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2013-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5b327806e811ef36ee96dae49aa4ebe |
publicationDate |
2013-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-8435525-B1 |
titleOfInvention |
FGF modulation of in vivo antibody production and humoral immunity |
abstract |
The invention provides methods for increasing or decreasing antibody production in vivo by inhibiting or promoting the activity of fibroblast growth factor-2 (FGF2) respectively. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013236474-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9107908-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016060334-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9359433-B2 |
priorityDate |
2010-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |